2540KRW
18.86 BKRW
6.24 BKRW
9.54 M
About INBIOGEN
Sector
Industry
CEO
Ji-Yeon Kang
Website
Headquarters
Pyeongtaek
Employees (FY)
64
Founded
2008
ISIN
KR7101140002
FIGI
BBG000V0TPL4
INBIOGEN CO., Ltd. engages in the manufacture and sale of footwear products. It operates through following business divisions: Shoes, Energy, and Other. The Shoes business operates through following brands: Artis, Champion, Wangja, and Specs. The Energy business offers wood pellet and sawdust. The company was founded on March 5, 2008 and is headquartered in Pyeongtaek, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 101140 is 9340 KRW — it has decreased by 2.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange INBIOGEN stocks are traded under the ticker 101140.
101140 stock is 5.19% volatile and has beta coefficient of 0. Check out the list of the most volatile stocks — is INBIOGEN there?
Yes, you can track INBIOGEN financials in yearly and quarterly reports right on TradingView.
101140 net income for the last quarter is −562.46 M KRW, while the quarter before that showed 807.38 M KRW of net income which accounts for −169.67% change. Track more INBIOGEN financial stats to get the full picture.
No, 101140 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 101140 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INBIOGEN stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 64.00 employees. See our rating of the largest employees — is INBIOGEN on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INBIOGEN technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INBIOGEN stock shows the strong sell signal. See more of INBIOGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INBIOGEN EBITDA is −4.99 B KRW, and current EBITDA margin is −80.04%. See more stats in INBIOGEN financial statements.